Phase II trial of PCNU in non-small cell lung cancer

  • L. A. Kalman
  • , M. B. Stoopler
  • , E. S. Casper
  • , D. P. Kelsen
  • , M. G. Kris
  • , R. J. Gralla

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

The authors conclude that PCNU, at the dose and schedule administered, does not have useful activity in patients with non-small cell lung cancer.

Original languageEnglish (US)
Pages (from-to)837
Number of pages1
JournalCancer Treatment Reports
Volume67
Issue number9
StatePublished - 1983
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Phase II trial of PCNU in non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this